Wegovy, also known as semaglutide, is a once-weekly injectable medication approved by the FDA for the treatment of obesity and overweight-related comorbidities such as type 2 diabetes. It works by mimicking the effects of the hormone GLP-1, which regulates appetite and glucose metabolism, helping individuals to lose weight and improve their blood sugar control. It is only available by prescription and has shown to be effective in clinical trials.
[toc]
Semaglutide
Semaglutide is a ...
